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All cells exist within a context. They are often
in contact with other cells or they may be bound
by the extracellular matrix (ECM). The micro-
environment around a cell, including interac-
tions with neighboring cells and the ECM, has
been shown to effect morphology, DNA synth-
esis, and even gene expression [Gospodarowicz
et al., 1978; Bissell et al., 1981]. These signals
dictate how a cell responds to its surroundings.
In normal tissue, cells are governed by a given
set of rules such as contact inhibition and
apoptosis, but transformed cells disregard these
rules by forming clumps of cells, moving
through complex matrices, and ignoring com-
mands for programmed cell death. Understand-
ing what messages cells obtain from their
surroundings, how they interpret these mes-
sages, and how they respond is an important
dynamic of both normal and pathologic cell
biology.
The tissue matrix is the physical framework
connecting the components of a cell with the
ECM [Isaacs et al., 1981; Fey et al., 1984; Pienta
et al., 1993]. The tissue matrix is a three
dimensional structure which links the chromo-
somes to the nuclear matrix, followed by the
cytoskeleton, membrane matrix, and ECM. The
nuclear matrix has several functions including
determining nuclear morphology [Berezney
and Coffey, 1974], providing DNA organization
and scaffolding [Pienta et al., 1991], replicating
DNA [Vogelstein et al., 1980], and transcribing
RNA as well as directing RNA transport [Ciejek
et al., 1982]. The cytoskeletal matrix is com-
posed of intermediate ®laments (IFs), actin
micro®laments, and microtubules and plays a
role in cytokinesis and mitosis. IFs speci®cally
have been shown to provide direct contact
between the nuclear matrix and the cyto-
skeleton.
A cell interacts with its microenvironment
through the membrane matrix, proteins and
glycoproteins imbedded in the plasma mem-
brane. Protein±protein interactions have been
shown to be an important component not only
for cellular adhesion, but also for signal trans-
duction. Cell surface integrins, a family of
heterodimeric glycoproteins, have been well
described as binding to speci®c RGD sequences
found in collagen and other membrane proteins
[Ruoslahti and Obrink, 1996; Gahmberg et al.,
1997]. The cytoplasmic domains of integrins
have been shown to bind to essential cytoskele-
tal proteins such as talin and a-actinin, and
activate focal adhesion kinase in creating adhe-
sion complexes. By interacting with the ECM
and neighboring cells through the adhesive
properties of its external domain, and the
cytoskeletal framework with its cytoplasmic
domain, integrins demonstrate an ability to
bridge the gap between mechanical adhesion
and intracellular signaling.
While much focus in the ®eld of cell adhesion
and ECM interactions has been placed on
integrins and protein±protein interactions, we
are only just beginning to understand the
spectrum of protein±carbohydrate interac-
tions. Breaking the DNA and polypeptide codes
has allowed the in-depth study of the passage of
genetic material, mutations of this system, and
its expression into proteins. Both DNA and
polypeptides represent linear codes with per-
mutations of a limited set of units. Carbohy-
drates, by containing branched chains and
additional sulfate, phosphate, or O-acetyl
groups, have a variety of organizational
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combinations that allow for an impressive array
of three dimensional structures [Sharon and
Lis, 1997]. For only three hexose monosacchar-
ides, there are 1,056 potential oligosaccharides,
and with the addition of each sugar unit there is
an exponential increase in the number of
possible structures. The potential biologic
diversity of these carbohydrates, in terms of
sequence and conformation, makes it an attrac-
tive system for conveying biologic information,
and was initially called the glycocode by Kasai
and Hirabayashi [1996]. With the ubiquitous
presence of carbohydrates on cell surface glyco-
proteins as well as throughout the ECM, it is
likely that cells use this glycocode to interpret
their surroundings, bind with increased speci-
®city, and interact with surrounding cells.
LECTINS
Lectins represent a diverse category of carbo-
hydrate binding proteins [Gabius, 1994, 1997].
Lectins have highly conserved carbohydrate
binding regions and have been identi®ed in a
broad range of multicellular organisms ranging
from nematodes to humans [Kasai and Hira-
bayashi, 1996]. Five distinct types of lectins
have been described including the C-type, the P-
type, the I-type, pentraxins, and galectins (S-
type). They share the property of having con-
served carbohydrate recognition domains
(CRDs), but with different binding motifs and
target ligands they clearly represent distinct
families [Drickamer, 1995].
Lectins have many ways of binding to their
ligand (Fig. 1) [Kaltner and Stierstorfer, 1998].
Simple models may include interactions
between a cell-bound lectin to a carbohydrate
found on another cell or the ECM. To add a level
of complexity, soluble carbohydrate moiety may
bind lectins on two surfaces, or even on the same
surface, which is known as ``bridging.'' In addi-
tion, some lectins have been shown to bind both
carbohydrates and proteins in a non-competi-
tive fashion. Lectins are also secreted where
they may interact in a paracrine or autocrine
fashion.
The C-type lectins are distinguished in their
requirement for Ca2 ions for sugar binding, in
addition to having a highly conserved CRD
domain [Drickamer, 1993]. This family of
lectins includes the selectins (L, P, and E), as
well as CD 69, CD 72, and the Asialoglycopro-
tein receptor. P-type lectins have been shown to
be involved in routing lysosomal enzymes and
are thought to orient enzymes that can degrade
proteoglycans in the ECM [Kornfeld, 1992]. The
I-type lectins share a characteristic immuno-
globulin-like CRD. I-type lectins can undergo
homophilic and heterophilic interactions
Fig. 1. Lectin signaling to the nuclear matrix through possible
pathways. Cell±cell interactions (A±C), cell±matrix interactions
(D±F), and solubilized (G). Lectins may also interact indepen-
dently through carbohydrate and protein interactions (C and F).
124 Chay and Pienta
[Zanetta, 1997] and include ICAM, PECAM, N-
CAM, and Po glycoprotein. Pentraxins form a
distinct pentameric con®guration and include
the acute phase reactants C-reactive protein
(CRP) and serum amyloid P (SAP). Their
ligands have been found on numerous micro-
organisms and CRP has been shown to activate
the complement cascade.
Galectins share a conserved CRD and bind
speci®cally to b-galactosides. Nine galectins
have been identi®ed to date, of them galectin-1
and -3 are the best studied. Galectin-1 is
ubiquitously found and because it exists as a
homodimer it is thought to allow for carbohy-
drate cross-linking. Galectin-3 functions as a
monomer, and has been shown to be present on
the plasma membrane as well as secreted as a
response to stress or in¯ammation [Sato and
Hughes, 1994]. Galectin-3 has also been found
on many tissues and it has been shown to be
involved in a wide range of functions including
cell adhesion [Sato and Hughes, 1992], angio-
genesis [Nangia-Makker et al., 2000], and the
recruitment of macrophages.
While galectins represent a relatively small
family compared to the C-type lectins, their
biologic functions tend to be less well de®ned.
Even their cellular localization is controversial
in that they have been identi®ed both in the
nucleus and the cytoplasm, as well as the
plasma membrane and the ECM [Barondes,
1984; Cooper and Barondes, 1990]. As proposed
by Kasai and Hirabayashi [1996], it is possible
that lectins may represent a category of proteins
which may transduce carbohydrate signals. We
would propose that in relaying and interpreting
the glycocode found as molecular signals in the
microenvironment, lectins may alter the
nuclear matrix through the tissue matrix to
affect alterations in cellular response.
Lectins and the Nuclear Matrix
From what is known about lectins, it is clear
that they are present on the plasma membrane
or are secreted and they can interact with the
ECM. Studies have shown that lectins are
involved in a variety of functions, with galectins
having the most diverse effects. The C-type and
I-type lectins have been shown to be involved
with different forms of cellular adhesion. The
P-type lectins are involved in intracellular
shuttling and ECM degradation. The role of
the galectins remains somewhat less clear.
They have been implicated in a wide variety of
complex activities, which suggests that they
act not only as sensors of the cellular micro-
environment, but they may have the ability to
interpret or at least transduce these signals.
The ECM has been shown to affect both the
cytoskeleton and the nuclear matrix. Getzen-
berg et al. [1991] showed that the ECM can alter
the tissue matrix as displayed on two-dimen-
sional gels. This suggests that the cell receives
signals as to its surrounding ECM and triggers
speci®c changes in tissue matrix proteins. A
recent study by Lelievre et al. [1998] has shown
altered expression of speci®c nuclear matrix
proteins with changes in the ECM. When a
human mammary epithelial cell line (HMEC)
was grown in three-dimensional reconstituted
basement membrane, they noticed changes in
cellular morphology. The nuclear matrix pro-
teins NuMA, splicing factor SRm160, and Rb,
showed altered spatial arrangement compared
to nuclear lamina protein and lamin B, which
remained unchanged. These studies support
the ®nding that the ECM can affect the tissue
matrix not only in terms of morphology, but
spatial changes in speci®c nuclear matrix
proteins have also been observed.
Changes in the nuclear matrix require some
form of signaling from the ECM. There is
evidence that lectins may transmit changes in
the microenvironment either through classical
signal transduction mechanisms or by altering
the cytoskeleton. In the model of neutrophil
adhesion, l-selectin, a C-type lectin, can acti-
vate the MAPK pathway through src-tyrosine
kinase p56lck [Brenner et al., 1996; Villalobo and
Gabius, 1998]. In addition, this stimulates Ras
activation of Rac with signaling through JNK/
SAPK. These pathways lead to the activation of
multiple transcription factors, which can result
in proliferation, differentiation, and cellular
activation.
In addition to classical signal transduction
pathways there have been observations that
lectins may alter the tissue matrix. Arena et al.
[1990] treated cultured chick embryo skin
®broblasts with the lectins PNA and SBA. They
observed that these exogenous lectins caused
alterations in the arrangement of various
cytoskeletal components including myosin,
actin, and tubulin. This resulted in changes in
the cellular morphology. More speci®cally,
Fulgenzi et al. [1998] have observed that the
lectin, comitin, can bind F-actin. Prior studies
had shown an interaction between comitin and
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F-actin, but by electron microscopy they
observed that comitin binds F-actin in areas
distinct from actin binding proteins. This
suggests that it may be important for the cell
not to have comitin compete with other skeletal
proteins due to its function. The third compo-
nent of the cytoskeleton, IFs, is likely to play the
most signi®cant role in mediating lectin signal-
ing. Traub et al. [1985] have suggested that IFs
may even directly interact with chromosomes
by showing that cytoplasmic adhesion mole-
cules can bind DNA, RNA, and histones in vitro.
This would suggest that IFs may bridge the gap
between the cytoskeleton and signaling to
components of the nuclear matrix to affect
DNA transcriptional regulation, but speci®c
sequences and regulatory processes have not
yet been described.
Signaling from adhesion complexes involving
both integrins and lectins in an integrated
fashion has not only been shown to occur via
cytoskeletal components, but studies suggest
that components of these adhesion complexes
may have a role directly in the nuclear matrix.
Connective membrane skeletal (CMS) proteins
help to form focal adhesion complexes, which
combine integrins and lectins with cytoskeletal
components and signal transducing kinases
[Lelievre and Bissell, 1998]. These CMS pro-
teins, including b-catenin, plakoglobin, plako-
philin 2, and zyxin, have been identi®ed in the
nucleus. In addition, some are simultaneously
associated with the nucleus and the plasma
membrane. The identi®cation of CMS proteins
in the nucleus has been observed in cells that do
not use them in cellular adhesion, as well as in
cells with disrupted adhesion complexes. This
raises the question whether these proteins may
act as pathways for the cytoskeleton to relay
changes to the nucleus and possibly alter the
nuclear matrix. The CMS protein b-catenin has
been shown to form a complex with the
transcription factor LEF-1 and bind to the 50
end of the E-cadherin gene, suggesting one
possible mechanism of cytoskeletal proteins
affecting the nuclear matrix to modulate gene
expression [Huber et al., 1996]. It is possible
that these proteins may play other roles at
various steps of gene expression such as
transcriptional activation or suppression,
nuclear traf®cking of mRNA, and one could
even envision actions on the spatial alignment
of inducer sequences to promote gene expres-
sion and DNA organization.
While there is evidence of signaling by lectins
via the tissue matrix, the more compelling effect
on the nuclear matrix is the ability of lectins to
alter cellular functions. Knowing that lectins
may act in a paracrine fashion, [Inohara et al.
[1998] have shown that soluble galectin-3 can
stimulate cell proliferation. Not only was this
response dose-dependent, but the effect could be
blocked by competing away the lectin binding
with lactose. In similar experiments they
examined the effect of galectin-3 on the endothe-
lial cell line HUV-EC-C [Nangia-Makker et al.,
2000]. The addition of galectin-3 caused
increased organization of the cells into tubules
when cultured on matrigel. Again, this was
dose-dependent and the effect could be com-
peted away with lactose and an antibody to
galectin-3. In addition, an in vivo matrigel assay
was performed to assess neovascularization.
They found no vessels in the matrigel injected
under the skin of mice, whereas the matrigel
imbedded with galectin-3 had an increased
microvessel density suggesting a role for galec-
tin-3 in angiogenesis.
Direct evidence of lectin involvement in the
nuclear matrix has come from Wang et al.
[1995]. In a series of experiments they demon-
strated that galectin-3 is associated with the
nuclear matrix. In addition, they showed that
galectin-3 binds both ssDNA and RNA. Inter-
estingly, these functions are not competed away
with carbohydrates suggesting that a different
region of the protein than the CRD is used for
nucleic acid interactions. These observations
support prior research suggesting that galectin-
3 is associated with riboneucleoprotein com-
plexes and can act as a pre-mRNA splicing
factor. Together, these studies show that galec-
tin-3 can not only recognize carbohydrate
moieties, but they suggest that through other
epitopes it can act on the nuclear matrix to
in¯uence complex functions such as cell prolif-
eration, morphology, and angiogenesis. These
effects may be mediated by changes in the tissue
matrix, nuclear matrix, and ultimately gene
expression, or possibly directly by galectin-3.
CONCLUSION
We are just beginning to understand the
functions of carbohydrate±protein interactions.
Carbohydrates have the potential to store a
wide range of biological information. Cellular
recognition of this glycocode has been conserved
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over evolution and several mechanisms of
carbohydrate binding have converged into hav-
ing similar functions despite coming from
disparate biologic origins. While smaller organ-
isms may have used these lectins for identifying
food sources in their environment, it has been
suggested that more complex, multi-organ
animals may use lectins for higher level orga-
nization [Kasai and Hirabayashi, 1996]. While
many of the lectins have rather speci®c func-
tions, the galectins have a broad range of
complex functions making them interesting
research targets. Studies utilizing molecular
and cellular biology techniques have identi®ed
their speci®c involvement in cell proliferation,
differentiation, and morphology. Due to our
limited knowledge of the glycocode it is possible
that our current techniques may be myopic and
not able to fully describe the potential organiza-
tional functions of lectins in general (see
Table I).
Spatial location has been alluded to in the
model of neutrophil adhesion for extravasation
into target tissues. It is well known that l-
selectin allows for the initial weak binding of
neutrophils to the endothelium forming the
cellular phenomenon known as ``rolling.'' This is
followed by the formation of a stronger bond
formed by integrins. This sequence has also
been described as ``lock & dock'' by Honn and
Tang [1992] and others. This model has often
been referred to in understanding cancer cell
metastasis, which appears to require a similar
set of events for cancer cell extravasation. While
this model describes a sequence for neutrophil
binding, it is not clear whether this is an
accurate model for the speci®city of cancer cell
adhesion and it leaves the question of how cells
pass through the endothelium to target tissues.
We would like to propose a model for ``lock, dock,
and entry'' (Fig. 2).
The endothelial cells, upon which neutrophils
and cancer cells initially bind, form a tight
barrier along the blood vessels. Carbohydrate
groups and L-selectin on the endothelial surface
have been shown to play important roles in the
initial steps of neutrophil adhesion. Studies
have shown that l-selectin can be upregulated
in both target tissues and in neutrophils during
in¯ammatory responses [Munro et al., 1996].
TABLE I
Potential organizational
roles of lectins Known correlates in function
Spatial location L-selectin mediated binding of neutrophils to the endothelium [Honn and Tang, 1992]
Cellular health status Upregulation of L-selectin in in¯ammation [Munro et al., 1996]
Rules of contact inhibition Alterations in cell membrane glycoproteins modi®es cell density and proliferation. [Wieser
and Oesch, 1988]
Stimulation and growth Growth effects mediated by galectin-3 [Inohara et al., 1998]
Organized cell death Overexpression of galectin-3 blocks apoptosis [Akahani et al., 1997; Matarrese et al., 2000]
Fig. 2. ``Dock, Lock, and Entry.'' This confocal microscopic
image depicts the adhesion of a PC-3 cell to a monolayer of
human bone marrow endothelial (HBME) cells. ``Dock'' refers
to the initial lectin binding followed by ``Lock'', the more tight
integrin binding. ``Entry'' refers to changes in the HBME cells
retracting from the PC-3 cell, which is mediated through an
unknown mechanism.
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Without a regulatory mechanism to increase
af®nity during an inciting event, binding would
be non-speci®c or constitutive. In terms of the
model for cancer cell metastasis, the problem is
somewhat different. The target tissue may be
perfectly healthy, but the cancer cell ®nds a
way, without an inciting event, to bind speci®-
cally. One potential model would be if cancer
cells could stimulate the regional production of
l-selectin. This would take advantage of known
mechanisms of neutrophil adhesion, but unlike
neutrophil adhesion, it still leaves open the
question of tissue speci®city. Neutrophils
potentially need to enter every tissue in the
body whereas tumor cells often metastasize to
speci®c tissues. The use of an l-selectin-
mediated pathway would implicate the poten-
tial for diffuse cancer cell adhesion. Another
potential model would be if every different area
of the vasculature bed had its own molecular
address. This could be accomplished by carbo-
hydrate presentation on the endothelial surface
based on the ECM created by the underlying
tissue. While initial adhesion may be non-
speci®c, it could be followed by a more speci®c
event, such as ``entry.''
The model of ``lock & dock'' only takes into
account cellular adhesion to the endothelial cell.
``Entry'' requires passage between the endothe-
lial cells. A model of ``entry'' involving destruc-
tion may presume that in response to cellular
attachment, adhesion molecules may signal a
change in the tissue matrix and allow for the
release of enzymes such as metalloproteinases
to degrade the ECM. While this may be
plausible for cancer cells, this seems unlikely
for neutrophils. This form of ``entry.'' could
produce in¯ammation and again cause an
upregulation of l-selectin. An alternative model
for ``entry'' involving communication would
suggest that the response to adhesion may not
be degradation, but instead signaling to the
endothelial cells a response. This response could
be mediated by protein±protein or carbohy-
drate±protein interactions. With the known
effects of lectins on cellular morphology, it is
plausible that a carbohydrate signal may cause
an alteration in the tissue matrix of the
endothelial cell to allow ``entry.'' This signal
could re¯ect molecular mimicry in presenting
like carbohydrates, or the signal could indicate
a command for ``entry.'' While these events
could be mediated by known protein±protein
and protein±carbohydrate interactions there is
no evidence that any known system alters
endothelial cells to allow for ``entry''.
While extravasation by neutrophils and can-
cer cells represents a complex system, it is
illustrative of the biologic use of carbohydrate±
protein interactions and their potential breadth
of involvement in regulating cellular function.
Despite techniques gained through our under-
standing of DNA and proteins, understanding
the glycocode and how to study it will be the
next frontier. There are several obstacles that
remain including understanding the mechan-
ism of deciphering the signal and how cellular
responses may then alter the presentation of
carbohydrates. Linear codes can be translated
in a linear fashion, but does the cell translate
the three dimensional structure of carbohy-
drates in one or multi-dimensions? In addition,
cellular responses may cause alterations in the
presentation of subsequent carbohydrate moi-
eties, but how long would this take and are there
other targets besides post-transcriptional mod-
i®cations in the Golgi complex? The answers to
these questions will likely hold the key to
cellular interactions on a molecular level as
well as cellular organization. Not only will this
have implications for the ®eld of metastasis, but
also organogenesis, tissue engraftment, and the
study of responses to infection.
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